- 专利标题： USE OF MELANOCORTINS TO TREAT INSULIN SENSITIVITY
-
申请号： EP15179111.8申请日： 2008-11-05
-
公开(公告)号： EP2979703B1公开(公告)日： 2018-07-18
- 发明人: HALEM, Heather A. , CULLER, Michael Dewitt , BUTLER, Andrew A.
- 申请人： IPSEN PHARMA S.A.S. , Board of Supervisors of Louisiana State University and Agriculture and Mechanical College
- 申请人地址： 65, Quai Georges Gorse 92100 Boulogne-Billancourt FR
- 专利权人： IPSEN PHARMA S.A.S.,Board of Supervisors of Louisiana State University and Agriculture and Mechanical College
- 当前专利权人： IPSEN PHARMA S.A.S.,Board of Supervisors of Louisiana State University and Agriculture and Mechanical College
- 当前专利权人地址： 65, Quai Georges Gorse 92100 Boulogne-Billancourt FR
- 代理机构： HGF Limited
- 优先权： US1933P 20071105
- 主分类号： A61K38/00
- IPC分类号： A61K38/00
摘要：
The present invention relates to peptide ligands of the melanocortin receptors, in particular the melancortin-4 receptor, and as such, are useful in the treatment of disorders responsive to the activation of this receptor, such as insulin resistance.
公开/授权文献
- EP2979703A1 USE OF MELANOCORTINS TO TREAT INSULIN SENSITIVITY 公开/授权日：2016-02-03
信息查询
IPC分类:
